Peptide Rb4, derived from protein proteolipid protein 2 (PLP2), acts directly on tumor cell multiplication inducing the expression of two DAMPs molecules, HMGB1 and calreticulin, which trigger immunoprotective effects in vivo against melanoma cells. The gene discussed is HMGB1; the disease is neoplasm.